Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: a SEER-Medicare analysis by Dai Chihara, Shibing Yang, Savreet Bains Chawla, Guihua Zhang, Anthony Wang, Junhua Yu, Donald Arnette, Fernando Rivas Navarro, Julie Blaedel, Alex Mutebi

Get full text

Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial by Paolo Strati, Lei Feng, Jason R. Westin, Ranjit Nair, Luis E. Fayad, Maria A. Rodriguez, Dai Chihara, Luis Malpica, Jared Henderson, Mariana Gallardo, Marissa Rivera, Iris Wang, Anastasiia Bolshakova, Anastasia Radko, David Kurtz, Stefan K. Alig, Christopher R. Flowers, Ash A. Alizadeh, Sattva S. Neelapu

Get full text

Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium by Jonathan R. Day, Melissa C. Larson, Urshila Durani, Jean L. Koff, Yucai Wang, Thomas M. Habermann, Izidore S. Lossos, Loretta J. Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin, John P. Leonard, Jonathon B. Cohen, Brad S. Kahl, Jia Ruan, W. Richard Burack, Jonathan W. Friedberg, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Matthew J. Maurer, Carla Casulo

Get full text

Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts by Patrizia Mondello, Brianna Negaard, Andrew L. Feldman, Brian K. Link, Carla Casulo, Dai Chihara, David Russler-Germain, Jason Romancik, Caitlin Gribbin, Sara Haddadi, Eric Mou, Ivana N. Micallef, Patrick B. Johnston, Joseph Novak, Yucai Wang, Rebecca L. King, Anne J. Novak, Thomas M. Habermann, Peter Martin, Brad Kahl, Grzegorz S. Nowakowski, Loretta J. Nastoupil, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos, Richard W. Burack, Matthew J. Maurer, Stephen M. Ansell

Get full text